MED Medifast Inc

Price (delayed)

$10.64

Market cap

$118.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.82

Enterprise value

$62.88M

?
Relative Growth: Rel. Growth: 4
Relative Strength: Rel. Strength: 32
Relative Valuation: Rel. Valuation: 63
Relative Profitability: Rel. Profitability: 29

Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a ...

Highlights
The company's quick ratio rose by 47% YoY and by 2.8% QoQ
MED's net income has shrunk by 186% YoY and by 7% QoQ
The EPS has dropped by 180% year-on-year and by 7% since the previous quarter

Key stats

What are the main financial stats of MED

MED stock price

How has the Medifast stock price performed over time
Intraday
-3.45%
1 week
-5.59%
1 month
-15.49%
1 year
-20.06%
YTD
-0.37%
QTD
4.42%

Financial performance

How have Medifast's revenue and profit performed over time
Revenue
$346.1M
Gross profit
$242.7M
Operating income
-$16.25M
Net income
-$20.02M
Gross margin
70.1%
Net margin
-5.8%
MED's net income has shrunk by 186% YoY and by 7% QoQ
The operating income has shrunk by 157% YoY and by 14% QoQ
Medifast's gross profit has decreased by 40% YoY and by 12% from the previous quarter
MED's revenue is down by 36% year-on-year and by 10% since the previous quarter

Price vs fundamentals

How does MED's price correlate with its fundamentals

Growth

What is Medifast's growth rate over time

Valuation

What is Medifast stock price valuation
P/E
N/A
P/B
0.59
P/S
0.34
EV/EBIT
N/A
EV/EBITDA
5.73
EV/Sales
0.18
The EPS has dropped by 180% year-on-year and by 7% since the previous quarter
MED's P/B is 89% below its 5-year quarterly average of 5.5
The equity has contracted by 6% YoY
The P/S is 56% lower than the 5-year quarterly average of 0.8 but 17% higher than the last 4 quarters average of 0.3
MED's revenue is down by 36% year-on-year and by 10% since the previous quarter

Efficiency

How efficient is Medifast business performance
MED's ROE has shrunk by 185% YoY and by 9% QoQ
The return on sales has dropped by 77% year-on-year and by 53% since the previous quarter
The return on invested capital has declined by 40% since the previous quarter and by 9% year-on-year
The ROA has decreased by 10% from the previous quarter

Dividends

What is MED's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Medifast financials performed over time
The company's quick ratio rose by 47% YoY and by 2.8% QoQ
MED's current ratio is up by 36% year-on-year and by 2.3% since the previous quarter
Medifast's debt is 92% less than its equity
Medifast's debt to equity has soared by 60% from the previous quarter and by 14% YoY
Medifast's debt has soared by 51% from the previous quarter and by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.